Altamira Therapeutics Ltd. Cash Flows From Used In Operating Activities Discontinued Operations
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Operating Activities Discontinued Operations of -CHF 1.09 million for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations · last filed 2025-04-30
CHF
| Period end | Cash Flows From Used In Operating Activities Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | -1.09M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | -1.10M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | -2.61M CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Cash Flows From Used In Operating Activities Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | -$1.22M 20-F · filed 2025-04-30 |
| 2022-12-31 | -$1.16M 20-F · filed 2025-04-30 |